首页> 外国专利> Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and related methods for identifying agents to overcome resistance

Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and related methods for identifying agents to overcome resistance

机译:慢性粒细胞性白血病获得性耐药的细胞培养模型及鉴定抗药性的相关方法

摘要

A method of generating a chronic myelogenic leukemia (CML) acquired chemoresistant culture model is provided. Such a method may comprise providing a naïve blast crisis CML cell line; administering/contacting the cell line with a mutation-inducing dose of imatinib; maintaining a culture of the treated cell line for a period of time until the treated cell line relapses and repopulates the culture; and determining the repopulated cell culture is a CML acquired chemoresistant cell line by detecting a BCR-ABL mutation, wherein the acquired chemoresistance is achieved by a BCR-ABL mutation.
机译:提供了一种产生慢性骨髓性白血病(CML)获得性化学抗性培养模型的方法。这样的方法可以包括提供幼稚的原始危机CML细胞系;给细胞系/诱导突变剂量的伊马替尼接触;维持经处理的细胞系的培养物一段时间,直到经处理的细胞系复发并重新填充培养物;并且通过检测BCR-ABL突变来确定CML获得的化学抗性细胞系是再生的细胞培养物,其中获得的化学抗性是通过BCR-ABL突变实现的。

著录项

  • 公开/公告号US9176114B2

    专利类型

  • 公开/公告日2015-11-03

    原文格式PDF

  • 申请/专利权人 CITY OF HOPE;

    申请/专利号US201313922141

  • 申请日2013-06-19

  • 分类号A61K35/14;C12N5/0786;C12N5/09;C12P19/34;G01N33/50;

  • 国家 US

  • 入库时间 2022-08-21 15:20:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号